Cohen Veterans Bioscience Virtually Attending & Exhibiting at the 2020 CNS Summit
October 23, 2020Read moreWe are excited to virtually attend and exhibit at the 2020 CNS Summit, October 29 – November 1, 2020.
This annual event convenes innovators across industry, academia, media, non-profit organizations, and others to enable networking, discussion, and collaboration in clinical development.
Dr. Andreas Jeromin featured as a speaker at the 2020 Virtual World Congress of Psychiatric Genetics, October 16-22
October 23, 2020Read moreOur Chief Scientific Officer Dr. Andreas Jeromin presented a symposium titled “Understanding the Biology of Posttraumatic Stress Disorder: Genome-Wide Association Studies, Phenotyping Strategies, Multivariate Gene-Environment Interactions, and Translational Research” at the 2020 Virtual World Congress of Psychiatric Genetics.
Dr. Allyson Gage featured as a speaker at Precision In Clinical Trials Virtual Summit (East Coast)
October 23, 2020Read moreOur Chief Medical Officer Dr. Allyson Gage presented at Precision in Clinical Trials Virtual Summit (East Coast); her presentation was titled “Transforming Clinical Research: Challenges & Opportunities in CNS Biomarkers”.
Dr. Lee Lancashire featured as a Keynote Speaker at the 2020 Bio-IT World Virtual Conference & Expo
October 23, 2020Read moreOur Chief Information Officer Dr. Lee Lancashire was a keynote speaker at Bio-IT World Virtual Conference & Expo 2020, contributing to a panel discussion titled “Game On: How AI, Citizen Science, and Human Computation Are Facilitating the Next Leap Forward”.
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
October 19, 2020Read moreCohen Veterans Bioscience announced findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder (PTSD) or major depressive disorder (MDD) towards the most effective treatment.
News
